Second Generation Grp94‐Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer
- 30 August 2017
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 23 (62) , 15775-15782
Abstract
Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum (ER) resident isoform of the 90 kDa heat shock protein (Hsp90) family and its inhibition represents a promising therapeutic target for the treatment of many diseases. Modification of the first generation cis‐amide bioisostere imidazole to alter the angle between the resorcinol ring and the benzyl side chain via cis‐amide replacements produced compounds with improved Grp94 affinity and selectivity. Structure–activity relationship studies led to the discovery of compound 30, which exhibits 540 nm affinity and 73‐fold selectivity towards Grp94. Grp94 is responsible for the maturation and trafficking of proteins associated with cell signaling and motility, including select integrins. The Grp94‐selective inhibitor 30 was shown to exhibit potent anti‐migratory effects against multiple aggressive and metastatic cancers.Keywords
Funding Information
- National Eye Institute (EY024232, EY021205)
- National Cancer Institute (F99CA212467)
This publication has 40 references indexed in Scilit:
- Development of a Grp94 inhibitorJournal of the American Chemical Society, 2012
- GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulumBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic DomainJournal of Biological Chemistry, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug DesignJournal of Molecular Biology, 2009
- Structures of GRP94-Nucleotide Complexes Reveal Mechanistic Differences between the hsp90 ChaperonesMolecular Cell, 2007
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007